AU701272B2 - Insect repellant - Google Patents

Insect repellant Download PDF

Info

Publication number
AU701272B2
AU701272B2 AU40286/95A AU4028695A AU701272B2 AU 701272 B2 AU701272 B2 AU 701272B2 AU 40286/95 A AU40286/95 A AU 40286/95A AU 4028695 A AU4028695 A AU 4028695A AU 701272 B2 AU701272 B2 AU 701272B2
Authority
AU
Australia
Prior art keywords
composition
liposomes
pyridinethione
water
dispersion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU40286/95A
Other versions
AU4028695A (en
Inventor
W. Blair Geho
John R. Lau
Darryl H. Woods
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SDG Technology Inc
Original Assignee
Technology Unlimited Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU56660/90A external-priority patent/AU5666090A/en
Application filed by Technology Unlimited Inc filed Critical Technology Unlimited Inc
Priority to AU40286/95A priority Critical patent/AU701272B2/en
Publication of AU4028695A publication Critical patent/AU4028695A/en
Application granted granted Critical
Publication of AU701272B2 publication Critical patent/AU701272B2/en
Assigned to SDG, INC. reassignment SDG, INC. Alteration of Name(s) in Register under S187 Assignors: TECHNOLOGY UNLIMITED INCORPORATED
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/24Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients to enhance the sticking of the active ingredients
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants

Description

t'ILu.u I I 28&g1 Regulation 3.2(2) It I
AUSTRALIA
Patents Act 1990
ORIGINAL
COMPLETE SPECIFICATION STANDARD PATENT Application Number: 40286/95 Lodged: 7 DECEMBER, 1995 o a a 9 a 9 a 9 9 a a a .9 a.a 99c 9 9 9a a 9 a a.
a a Invention Title: INSECT REPELLANT The following statement Is a full description of this Invention, Including the best method of performing It known to us INSECT REPELLANT BACKGROUND OF THE INVENTION Field of the Invention Emulsions are formed from molecules that are not very soluble in aqueous media, but are soluble in organic solvents.
A species of the field is the establishment of a delivery system using a liposomal emulsion delivery system for targeting and anchoring aromatic hydrocarbons, such as mosquito repellants and insecticides, to the stratum corneum.
Liposome and vesicle will be used interchangeably herein, because the art is not sufficiently exact with respect to the parameters of nomenclature.
Description of Prior Art Liposomes are known to encapsulate and thereby sequester water soluble pharmacological agents. Thus, these agents are separated from the surrounding media. The liposomes have potential for cite specific delivery, as presented by the prior art, for their use as carriers to enhance therapeutic and protective indices.
Achieving controlled release of volatile substances such ds insect repellants, has been the object of intense effort for several decades. However, 20 only a few reports of actual success to limited systems are known. Literature to studies indicate that most success in this area has been through the use of polymers, resins and impregnated gel beads and silica. These prior art systems provide only minimal accuracy and afford less than satisfactory control over to. release of the product.
This invention distinguishes over all known prior art, including intensive literature studies, by the discovery that formation of bipolar lipids into vesicles in the presence of organic molecules that are minimally soluble in aqueous media, S exhibit a phenomena of physical entrapment of the organic solvent in the manner illustrated in the drawings. The organic solvent would not ordinarily be ~30 expected to fill the core of a vesicle/liposome during formation, because the outermost portion of a lipid membrane, both on the exterior surface and on the core volume wall, is a hydrophilic sphere and therefore it is generally assumed that an organic solvent would not be encapsulated.
2 It is an ubject of this invention to provide a slow release delivery system for chemicals which are soluble in an organic solvent, by sequestering the chemical in a bipolar vesicle.
Another object of the invention is to provide a target molecule for such sequestered agent, the target molecule being selected to have affinity for the desired host surface under consideration.
SUMMARY OF THE INVENTION The present invention is an insect repellent or insectidical composition for application to the skin of a user, which composition includes an insect repellent or insecticide soluble in organic solvents are substantially insoluble in water, the insect repellent or insecticide being encapsulated within liposomes dispersed in an aqueous environment, characterised in that said liposomes further includes sodium pyridinethione or zinc pyridinethione as an anchoring molecule attached to the liposomes so as to confer on the liposomes an affinity for stratum corneum.
The present invention also relates to a process for the manufacture of the above composition particularly when the liposor!tes include hydroxylated lecithin, said process including the steps of: a) forming a dispersion of hydroxylated lecithin in water; 20 b) forming a solution of sodium pyridinethione or zinc pyridinethione in water; t: c) sonicating the dispersion formed in step a) whilst adding the solution formed in step to form a liposomal dispersion, and 2d) mixing said liposomal dispersion with an insect repellent or 25 insecticide soluble in organic solvents and substantially insoluble in water.
SThe term "burden" as used herein shall refer in general to a biological S effective chemical for application to a living host skin surface, to elicit a desired :I response.
The terms "comprising", "comprises", "including" and "includes" as used herein are to be taken to specify the presence of the stated features, integers, steps or components but does not preclude the presence or addition of one or more other features, integers, steps or components or groups thereof.
2a The burden is sequestered in a bipolar vesicle, or entrapped in a fragment thereof.
Application of an environment enhancement chemical to the skin of a warm blooded host is accomplished by performing liposomal emulsification of the enhancement chemical, and anchoring the liposome to the stratum corneum by means of a targeting molecule having a lipophilic moiety engaged into the liposome, and having a moiety with affinity for the stratum corneum.
A specific example is the emulsification of molecules that are not very soluble in aqueous media but show solubility for lipid phase and organic solvents. For example, one embodiment is 6,12 (2 Ethyl-l, 3,-hexanediol) and N,N-Diethyl-m-toluamide (DEET).
Flea and tick repellents and/or insecticides are further examples.
The drawings illustrating this invention show the discovered unique sequestering of the described class of water insoluble burden. Liposomes cannot be formed in an organic solvent, and water insoluble chemicals cannot be trapped in a core volume of a lipid vesicle. This invention discloses the phenomena of physically sequestering organic soluble material.
":Then, by attaching a targeting molecule an article of manufacture is produced which will attach to a targeted skin cell. For example, by targeting the human stratum corneum with pyridinethione, sequestered DEET will gradually :escape its sequestering lipid, and repel or kill insects for an extended period of 3 BRIEF DESCRIPTION OF THE DRAWINGS The single figure is a five step sequence taken from electron micrographs.
DEFINITI N Because the invention is in the unique means for dispensing a biologically active substance such as an insect repellant or insecticide, and not in the substance per se, reference hereinafter for disclosure will be limited to "insect repellant" for economy of expression, and shall include any substance embraced in the generic term "biologically active substance".
DETAILED DESCRIPTION First Example One preferred embodiment of the invention is to provide an article of manufacture for repelling or killing insects, comprising a substantially water insoluble organic compound DEET, or a pesticide, loaded to a bipolar lipid body. A targeting molecule, for anchoring the lipid body, has a lipid soluble moiety united to the lipid body, and a target moiety having affinity for stratum corneum.
As stated, the prior art method of making vesicles or liposomes is to subject a mixture of bipolar lipid, such as egg lecithin, and an aqueous solution 20 of the intended burden, to high energy input such as sonication or microfluidization. The bipolar lipid breaks into smaller units and forms bladders known as a vesicle or liposome. In the process some of the aqueous media is captured in the core volume of the liposomes. This basic known system is satisfactory for aqueous media but is inoperative for organic molecules that are 25 minimally soluble in aqueous media.
In this example, a lecithin is first polytroned and then microfluidized or sonicated to create very large multilamellar liposomes. Although a separate step may be employed, it has been found practical to carry out a simultaneous reaction by including in the mixture of lecithin and aqueous media, a burden 30 such as DEET. The DEET molecule possesses hydrophobic (lipid seeking) groups such as the ethyl moiety and the paramethylbenzene rings. The lipid seeking nature of the DEET molecule allows it to seek and penetrate a large
I
4 multilamellar liposome so that the lipid domain of the liposome actually is disrupted and penetrated by the DEET molecule. The capture of the DEET molecule is illustrated in the five-step illustration in the drawing, which are reproductions of actual images from electron microscopy. The small black spot represents a particle of DEET and the multilamellar rings represent a larger liposome.
The liposome, no longer being intact, is simply a large multilamellar array of lipid which seeks to repair itself thermodynamically and in so doing emulsifies the DEET particle or molecule by surrounding the DEET with the large multilamellar array. The DEET particle thus has been sequestered and protected by lipid. This is not a liposome or a vesicle in the classical sense because the core volume is not aqueous but rather is organic. The organic particle of DEET seeks to exclude core volume water.
This concept may be considered as a semi-classical emulsion. It has all the characteristics of an emulsion. It breaks upon freezing and warming causing the DEET to coalesce and partition into a larger separate phase. The liposomal lamellae are acting as an emulsifying agent. The major portion of the lamellae evidence a distorted non-spherical pattern, as illustrated in the drawing, as they attempt to emulsify the DEET particles progresses.
20 The manner in which the emulsification effect differs from classical emulsions is that the emulsifying agent has lamellae or onion skin kinds of structures and these structures have been preformed in a single step. A multiple protective layer pattern has been developed that will emulsify the DEET.
The described liposomal emulsion system has captured or sequestered 25 DEET in a new way based on emulsion chemistry. It is apparent that once the DEET has been emulsified by the onion skin lamellae, its escape to the atmosphere is restricted and slowed. This concept forms the basis for timed release of water insoluble substances such as DEET and prolongs their duration of action.
30 The above-described article of manufacture may be employed in the described state and can cling to skin and hair for a period of time. However, a vastly improved result is obtained by employing a variety of skin substantive molecules such as pyridinethione and the derivatives described herein to anchor the lipid and its burden to skin of the host for the purpose of maintaining a slow time-release of the active product onto the skin surface and surrounding area.
The target pyridinethione is a molecule having a lipid soluble moiety and a hydrophilic moiety and therefore the lipid soluble moiety will penetrate the wall of the emulsified array and extend the hydrophilic moiety away from the surface to act as a targeting agent for attaching the completed article of manufacture to the corneum stratum.
Second Examle Close examination of the mixture which has been polytroned and subjected to either sonication or microfluidization reveals that not all of the lipid material has been formed into perfect liposomes as illustrated in the drawing.
There remains fragments of the liposomes which have a slightly curved configuration, as well as sheet-like fragments of bipolar lipid. If the intensity of the sonication or microfluidization is off of ideal, the resultant product can be essentially all fragments or bits of sheet bipolar lipid with few well formed liposomes. It is this type of product which heretofore has been considered to be essentially useless because of the small amount of well formed liposomes. It has been discovered, in working with this material, however, that contrary to expectations, a very effective delivery of DEET to the stratum corneum has actually been achieved.
The explanation for this unexpected phenomena is known as partitioning within multilamellar bilayers. It is a known fact that highly immiscible fluids, such 25 as oil and water, do have some degree of solubility one in the other. The amount of solubility will vary according to the particular ingredients, which solubility is obtainable from standard chemical tables.
Therefore, it has been discovered that those fragments and sheets which are not sufficiently large to envelope the DEET as illustrated, for example by the 30 completely formed vesicles, will nevertheless carry some of the DEET and also will accept the targeting molecule. Therefore, the degree of perfection toward
:P
forming of perfect vesicles is greatly reduced and the efficiency of the Smanufacturing process greatly increased.
,_II
6 Targeting Procedure Applicants recognize the ability of chelated zinc pyridinethione (ZPT) to adhere to stratum corneum. ZPT has the following structural formula: t N S O Zn----0 Since the zinc complex of ZPT shown above is much less soluble in aqueous media because of the ligand formation by the ionizable and hydrophilic functional groups, such as the sulfhydrals and oxygens, this molecule is an appropriate candidate as a liposome targeting agent. It can be incorporated in a one-step procedure into the liposome membrane during the time of sonication and microfluidization.
The procedure used for making the product as tested is set forth below: 1. 120 mg of the sodium salt of pyridinethione is dissolved in 525 ml of deionized water and allowed to stir at ambient temperature for 15 minutes.
2. 120 mg of hydroxylated lecithin is weighed into an 800 ml beaker while 15 525 ml of solubilized sodium pyridinethione is added in 100 ml aliquots. During pyridinethione addition, the sample is slowly polytroned with an ultra-Turrax TP- 18/1051 polytron from Janke and Kunkel IKA Laboratory, at setting #4 for minutes.
3. After the lecithin had been mixed, 180 ml of 100% diethyl-m-toluamide (DEET) was added to the 600 ml of sodium pyridinethione lecithin solution in three aliquots of 60 ml each, five minutes apart. After the last aliquot, the total volume of 825 ml was allowed to mix while polytroning on setting #4 for ~minutes. Then, 495 ml of deionized water was added and allowed to mix while polytroning on setting #4 for 30 minutes. The total volume of the solution at this point was 1320 ml.
L
\I
7 4. The 1,320 mi of the pyridinethione-lecithin DEET suspension was processed through the microfluidizer at a head pressure of 20 psig and a shear pressure of 2,500 psig. The total recoverable volume of 1,320 ml was recycled three times through the microfluidizer under the above conditions. The initial starting temperature of the suspension was 20 degrees C, and the final temperature following microfluidization was 63 degrees C.
I1 Ii @9 4 0* .4 a «p @4
S*
U
9« 4* 4 *9 t 4

Claims (6)

1. An isect repellent or insecticidal comp tition for application to the skin of a user, which composition includes an insect repellent or insecticide soluble in organic solvents and substantially insoluble in water, the insect repellent or insecticide being encapsulated within liposomes dispersed in an aqueous environment, characterised in the said liposomes further include sodium pyridinethione or zinc pyridinethione as an anchoring molecule attached to the liposomes so as to confer on the liposomes an affinity for stratum corneum.
2. The composition of Claim 1, wherein the composition contains sodium pyridinethione.
3. The composition of Claim 1, wherein the composition contains zinc pyridinethione.
4. The composition of Claim 1 or 2, which includes N,N-diethyl-m-toluamide.
The composition of any one of Claims 1 to 4, wherein the liposomes include hydroxylated lecithin.
6. A process for the manufacture of the composition of Claim 5, which process includes the steps of: forming a dispersion of hydroxylated lecithin in water; b) forming a solution of sodium pyridinethione or zinc pyridinethione in water; c) sonicating the dispersion formed in step a) whilst adding the solution formed in step to form a liposomal dispersion, and d) mixing said liposomal dispersion with an insect repellent or insecticide soluble in organic solvents and substantially insoluble in water. DATED this 12th day of November, 1998. TECHNOLOGY UNLIMITED INC. WATERMARK PATENT TRADEMARK ATTORNEYS 290 BURWOOD ROAD HAWTHORN VICTORIA 3122 1 AUSTRALIA (DOC06 AU4028695.WPC IAS-JGC:RES)
AU40286/95A 1989-05-25 1995-12-07 Insect repellant Ceased AU701272B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU40286/95A AU701272B2 (en) 1989-05-25 1995-12-07 Insect repellant

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35650689A 1989-05-25 1989-05-25
US356506 1989-05-25
AU56660/90A AU5666090A (en) 1989-05-25 1990-05-22 Insect repellant
AU40286/95A AU701272B2 (en) 1989-05-25 1995-12-07 Insect repellant

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU56660/90A Division AU5666090A (en) 1989-05-25 1990-05-22 Insect repellant

Publications (2)

Publication Number Publication Date
AU4028695A AU4028695A (en) 1996-02-15
AU701272B2 true AU701272B2 (en) 1999-01-21

Family

ID=25631417

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40286/95A Ceased AU701272B2 (en) 1989-05-25 1995-12-07 Insect repellant

Country Status (1)

Country Link
AU (1) AU701272B2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731210A (en) * 1981-01-07 1988-03-15 Hans Georg Weder Process for the preparation of liposomal medicaments
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4855090A (en) * 1987-03-13 1989-08-08 Micro-Pak, Inc. Method of producing high aqueous volume multilamellar vesicles

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731210A (en) * 1981-01-07 1988-03-15 Hans Georg Weder Process for the preparation of liposomal medicaments
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4855090A (en) * 1987-03-13 1989-08-08 Micro-Pak, Inc. Method of producing high aqueous volume multilamellar vesicles

Also Published As

Publication number Publication date
AU4028695A (en) 1996-02-15

Similar Documents

Publication Publication Date Title
DE69535297T2 (en) PREPARATION OF MULTIVESIC LIPOSOMES FOR THE TAXED RELEASE OF ACTIVE SUBSTANCES
DE69826256T3 (en) METHOD FOR INCREASING THE LIABILITY OF A PRODUCT ON A SURFACE
CA1253796A (en) Spray method and formulation for use therein
US5221535A (en) Sustained release formulations of insect repellent
CA1337262C (en) Time release protein
KR960005137B1 (en) Lipospheres for controlled delivery of substances
DE4309756B4 (en) Controlled release microcapsules and controlled release method of a chemical agent
US5055300A (en) Time release protein
US5518736A (en) Method of preparing natural-oil-containing emulsions and microcapsules and its uses
EP0729351B1 (en) Vesicles with controlled release of actives
DE3032616C2 (en)
US20090232855A1 (en) Percutaneous controlled releasing material using nano-sized polymer particles and external application agent containing the same
US5788975A (en) Improving the lasting properties of an odor by encapsulating an odoriferous ingredient
US5079005A (en) Time release protein
CA2280179A1 (en) Anti-parasitic action of n,n-diethyl-m-toluamide (deet) and formulations that prolong its activity in the skin
US5173303A (en) Cutaneous delivery of organic materials
WO2001064330A1 (en) Nanocapsules having a polyelectrolyte envelope
EP0473645B1 (en) Insect repellant
JPH11507926A (en) Pesticide aerosol spray composition
AU701272B2 (en) Insect repellant
DE102019119888A1 (en) New formulation based on an oleogel, especially for the release of volatile components and a process for its production
JP2003002806A (en) Ant proofing agent
CA2099093A1 (en) Organic envelopment
JPH01313407A (en) Soil treating agent for preventing termite
MXPA98006381A (en) Anti-parasitic action of n,n-diethyl -m-toluamide (deet) and formulations that prolong its activity in the skin.

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired